|
Volumn 17, Issue 6, 1998, Pages 565-570
|
Implications of pharmacokinetics in making choices for the management of acute otitis media
a,b |
Author keywords
Acute otitis media; Antibiotic; Pharmacokinetics
|
Indexed keywords
AMOXICILLIN;
AMOXICILLIN PLUS CLAVULANIC ACID;
AZITHROMYCIN;
CEFACLOR;
CEFDINIR;
CEFIXIME;
CEFPODOXIME PROXETIL;
CEFPROZIL;
CEFTIBUTEN;
CEFTRIAXONE;
CEFUROXIME AXETIL;
CEPHALOSPORIN DERIVATIVE;
CLARITHROMYCIN;
CLINDAMYCIN;
COTRIMOXAZOLE;
ERYTHROMYCIN;
LORACARBEF;
MACROLIDE;
OFLOXACIN;
PEDIAZOLE;
PENICILLIN DERIVATIVE;
ANTIBIOTIC THERAPY;
ARTICLE;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG COST;
DRUG DISPOSITION;
DRUG DISTRIBUTION;
DRUG EFFICACY;
DRUG EXCRETION;
DRUG INDICATION;
DRUG METABOLISM;
DRUG SAFETY;
OTITIS MEDIA;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
ACUTE DISEASE;
ANTI-BACTERIAL AGENTS;
BIOLOGICAL AVAILABILITY;
CHILD;
CHILD, PRESCHOOL;
DECISION MAKING;
DRUG UTILIZATION;
HUMANS;
INFANT;
OTITIS MEDIA;
|
EID: 0031862534
PISSN: 08913668
EISSN: None
Source Type: Journal
DOI: 10.1097/00006454-199806000-00037 Document Type: Article |
Times cited : (14)
|
References (12)
|